Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
110.41
-0.62 (-0.56%)
Jul 1, 2026, 4:00 PM EDT - Market closed
Rhythm Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $130 | Buy | Maintains | $130 | +17.74% | Jun 17, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $143 → $151 | Buy | Maintains | $143 → $151 | +36.76% | Jun 16, 2026 |
| Jefferies | Jefferies | Buy Maintains $125 | Buy | Maintains | $125 | +13.21% | Jun 15, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $158 → $159 | Buy | Maintains | $158 → $159 | +44.01% | Jun 15, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $136 | Buy | Reiterates | $136 | +23.18% | Jun 15, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $149 | Buy | Maintains | $149 | +34.95% | Jun 15, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $133 | Buy | Reiterates | $133 | +20.46% | Jun 15, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $143 | Buy | Reiterates | $143 | +29.52% | Jun 15, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.